Psychedelics are a hot topic in labs all over the world because they hold great potential for relieving the symptoms of depression, anxiety, PTSD and other mood-related conditions. Still, there is a major hurdle to developing ...
Apr 22, 2024
0
59
People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology ...
18 hours ago
0
1
The American Heart Association calls them "game changers."
Apr 22, 2024
0
1
Nearly 20% of fresh, frozen and canned fruits and vegetables that Americans eat contain concerning levels of pesticides, a new report finds.
Apr 18, 2024
0
20
Giving drugs at different times of day could significantly affect how they are metabolized in the liver, according to a new study from MIT.
20 hours ago
0
59
Research presents an advance in drug delivery and tissue implantation assisted by ultrasound, developed by researchers from the Technion Faculty of Biomedical Engineering. The work is published in the journal Small Methods.
Apr 22, 2024
0
0
US health authorities said Tuesday they had discovered fragments of bird flu virus in the nation's pasteurized cow milk supply during the course of a large study, but the samples likely posed no health risk to humans.
Apr 24, 2024
0
10
Even though fentanyl-linked fatal overdoses are soaring among young adults, a new survey of American college students found that just 1 in 7 knew how to administer the overdose antidote drug naloxone.
Apr 22, 2024
0
0
The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the brand name Anktiva, to be used in combination with the immunotherapy Bacillus Calmette-Guerin (BCG) ...
Apr 23, 2024
0
1
The U.S. Food and Drug Administration has approved Genentech's Alecensa (alectinib) as adjuvant treatment following tumor resection in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC).
Apr 23, 2024
0
0
